AzTrials
AzTrials

Wounds and InjuriesNCT06237283

Effects of Early Postoperative Showering After Coronary Artery Bypass Grafting Using Bilateral Internal Thoracic Artery

A study testing Early shower in people with Wounds and Injuries and Wound Infection, run by Sejong General Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study to evaluate effects of early postoperative showering after coronary artery bypass grafting using bilateral internal thoracic artery Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Wounds and Injuries, Wound Infection
What is being tested?
Early shower
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteSouth Korea
Study dates
3 Jan 2024to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 18
  • Patients who underwent coronary bypass grafting with bilateral internal thoracic artery through median sternotomy
  • Patients whose all drains or pacing wires are removed

Who cannot join

  • Concomitant operation
  • Redo-surgery
  • prolonged intensive care unit stay (more than 4 days) due to serious complications after surgery
  • open wounds
  • active infection
  • prolonged drains

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Bucheon Sejong Hospital

    Bucheon-si, Gyeonggi-do, 14754

    HEEMOON LEE, 82-10-9083-6249, rhythmists@gmail.com

    Recruiting

Other trials in South Korea

About this study

The study to evaluate effects of early postoperative showering after coronary artery bypass grafting using bilateral internal thoracic artery

Being tested
Early shower
Medical subject headings
Wounds and Injuries, Wound Infection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early showerBehavioural

    Start shower after drain removal

Study groups in NCT06237283
Study groupRoleWhat they receive
Early showerExperimentalStart shower after drain removal
Receives: Behavioral: Early shower
Late showerNo interventionStart shower after wound stitches are removed

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of deep sternal wound infection

    Measured: until 1 months after discharge

  2. Rate of superficial sternal wound infection

    Measured: until 1 months after discharge

  3. Rate of wound dehiscence

    Measured: until 1 months after discharge

Secondary outcomes (6)
  1. Patient satisfaction

    questionnaire

    Measured: at 1st outpatient clinic visit

  2. Rate of mortality

    Measured: until 1 months after discharge

  3. Rate of stroke

    Measured: until 1 months after discharge

  4. Rate of respiratory complications

    Measured: until 1 months after discharge

  5. Rate of bleeding requiring reoperation

    Measured: until 1 months after discharge

  6. Rate of low cardiac output syndrome

    Measured: until 1 months after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2024
  2. Study start3 Jan 2024
  3. Primary completion1 Mar 2025 (estimated)
  4. Study completion1 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06237283
Sponsor's protocol ID
BSH 2023-09-005
Status last verified
Jan 2024
First submitted
23 Jan 2024
Last updated
2 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Early shower in people with Wounds and Injuries and Wound Infection, run by Sejong General Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact HEEMOON LEE (82-10-9083-6249, rhythmists@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of deep sternal wound infection (time frame: until 1 months after discharge). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in